When was Lungpacer founded?

Lungpacer was founded in 2009 and raised its 1st funding round 4 years after it was founded.

Where is Lungpacer located?

Lungpacer is headquartered in Vancouver, Canada. It is registered at 2900 - 550 Burrard Street, Vancouver.

How many employees does Lungpacer have?

As of Mar 31, 2026, the latest employee count at Lungpacer is 58.

Is Lungpacer a funded company?

Lungpacer is a funded company, having raised a total of $121M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 13, 2013.

When was the latest funding round of Lungpacer?

Lungpacer's latest funding was a $***** Series B round on Mar 18, 2025, with participation from 0 investor.

Where does Lungpacer rank among its competitors?

Lungpacer ranks 3rd amongst 119 active competitors, of which 33 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Lungpacer, which secured $10M in Mar, 2025.

Who are the top competitors of Lungpacer?

Lungpacer's top competitors include Inogen, Belluscura and Laerdal Medical. Among them, Lungpacer secured the most recent funding round in March, 2025.

Lungpacer - 2026 Company Profile, Funding & Competitors

Company Details

Developer of a neurostimulation-based pacer for diaphragm strength. It provides lungpacer system that uses a minimally invasive, transvascular nerve stimulation technology to activate the diaphragm. Its electrodes are intravenously inserted into the lungs to rhythmically activate the diaphragm through neurostimulation to restore negative pressure ventilation. The pacing therapy is used to prevent or reverse diaphragm muscle-disuse atrophy and maintain diaphragmatic endurance.

Website: lungpacer.com
Social
Registered Address: 2900 - 550 Burrard Street, Vancouver

Key Metrics

Founded Year

2009

Location

Vancouver, Canada

Stage

Series B

Total Funding

$121M in 7 rounds

Latest Funding Round

Series B, Mar 18, 2025, $*****

Investors

New Enterprise Associates & 6 more

Ranked

3^rd among 119 active competitors

Employee Count

58 as on Mar 31, 2026

Similar Companies

Belluscura & 43 more

View Lungpacer's full profile

Lungpacer is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Lungpacer Medical, Inc. CIN: 718088-8 , Canada, Active	May 27, 2009	-	-	-

Lungpacer has raised a total funding of $121M over 7 rounds. Its first funding round was on Mar 13, 2013. Lungpacer has 7 institutional investors.

Here is the list of recent funding rounds of Lungpacer:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 18, 2025	6851087	Series B	5473390	5050528	2108760	2537906
Apr 13, 2022	4460615	Series B	3541402	6798387	8800300	6815863
Jan 15, 2021	6511857	Grant (prize money)	2696459	5954693	4090754	Military Health

Access funding benchmarks and valuations. Sign up today!

View details of Lungpacer's funding rounds and investors

Lungpacer's employee count trend

Lungpacer has 58 employees as of Mar 26. Here is Lungpacer's employee count trend over the years:

Uncover Lungpacer's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lungpacer include Inogen, Belluscura and Laerdal Medical. Here is the list of Top 10 competitors of Lungpacer, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Inogen 2001, Goleta (United States), Public	Provider of a portable oxygen concentrator for oxygen therapy	$51.6M	Novo Holdings, Western Technology Investment ... & 5 others	67/100
2nd	Belluscura 2015, Dallas (United States), Public	Provider of medical devices for laparoscopic procedures	$6.38M	Tekcapital	60/100
3rd	Lungpacer 2009, Vancouver (Canada), Series B	Developer of a neurostimulation-based pacer for diaphragm strength	$121M	New Enterprise Associates, KCK MedTech & 5 others	56/100
4th	Laerdal Medical 1940, Stavanger (Norway), Funding Raised	Therapeutic products, training and education for emergency care	-	Europa	55/100
5th	Fisher & Paykel Healthcare 1971, Auckland (New Zealand), Public	Manufacturer of treatment devices for sleep apnea for home and hospital settings	-	ELM Responsible Investments, South Bastion	54/100
6th	Noccarc 2017, Pune (India), Series A	Developer of smart ventilators for respiratory care	$6.35M	Indian Angel Network, SIDBI & 115 others	53/100
7th	Breathe Technologies 2005, Irvine (United States), Acquired	Portable respiratory therapy systems	$60M	TriplePoint Capital, Union Grove Venture Partners ... & 11 others	52/100
8th	hemovent 2013, Aachen (Germany), Acquired	Developer of equipment for extracorporeal life support	$16.7M	MIG Capital, NRW.Bank & 4 others	48/100
9th	TNI medical 2007, Wurzburg (Germany), Acquired	Artificial breathing aids	$3.39M	Pathena, Masimo & 1 others	48/100
10th	React Health 2010, Dublin (United States), Late Stage	Developer of medical devices for the treatment of sleep-disordered breathing and oxygen therapy	-	One Equity Partners, Palm Beach Capital	47/100